SIR-Syncope and unexplained falls are frequent reasons for emergency room visits and hospital admissions in elderly patients [1] . Results from the Framingham study showed that 10.5% of the population experienced one or more syncopal events during a 17-year period of observation. Although the overall incidence was 6.2 events per 1000 person-years, rates were significantly higher in elderly subjects (17 per 1000 person-years in males and 19 per 1000 person-years in females aged ≥80 years) [2] . Syncope has been reported to account for 3% of hospital emergency visits and 1-6% of admissions [3, 4] .
The tilt table test (TTT) is a valuable diagnostic tool to evaluate patients with syncope and unexplained falls [5, 6] . The safety of TTT has been proven in a large number of elderly patients [7] . A positive TTT (TTT+) is defined by a drop in systolic blood pressure (SBP) ≥50 mmHg, with production of symptoms of pre-syncope or syncope (with or without changes in heart rate) [6, 8] . TTT is usually conducted over 30-45 minutes with a technician and physician in attendance. Shorter durations are often offset by pharmacologic challenge (e.g. glyceryl trinitrate) [6] . The time and staffing requirements make TTT relatively underutilised in most centres. Therefore, any strategy that will allow better case selection or a shortened testing regimen may improve patient care.
The predictors of TTT+ remain largely unknown. It is theoretically possible that global autonomic dysfunction in these patients leads to significant haemodynamic changes during the early phases of tilting, antedating the dramatic blood pressure fall later during the test. However, the coexistence of other factors potentially affecting these changes, such as age, co-morbidities and different drug classes, prompts the need for adequately powered studies to adjust for these variables.
The main aim of our study was to identify the predictors of TTT+. In particular, we speculated that abnormal early haemodynamic responses to tilting might predict the test outcome.
Methods
We performed a TTT on 161 elderly patients (mean age 80.9 ± 5.9 years, mean ± SD), consecutively referred for tilt table testing in our Institution, for investigation of unexplained falls and/or syncope/pre-syncope. Exclusion criteria included history of ventricular arrhythmia, acute coronary syndrome or cerebrovascular accident within the last 3 months, documented severe left ventricular outflow tract obstruction, critical cardiac valvular lesions and Mini-Mental State Examination score <20 of 30. In addition, 15 subjects declined enrolment because of either physical inability to stand for the required time or pain. The study was performed according to the Declaration of Helsinki after being approved by the local research ethics committee. Each subject gave written informed consent before starting the study.
Tilt table test protocol
The tests were performed in a quiet room with dim lighting. Patients remained on their usual medications prior to testing. A qualified nurse and physician were present at all times. Blood pressure and heart rate were measured continuously using finger plethysmograph and surface electrocardiograph, respectively (TaskForce Monitor, CNSystems, Graz, Austria). After 10 minutes of resting supine, patients were tilted to 70° head-up. The tests were limited to 45 minutes. A drop in SBP ≥50 mmHg with production of any symptoms of pre-syncope or syncope was considered a positive test (with or without changes in heart rate).
Statistical analysis
Differences between groups were assessed using two-way ANOVA. Predictors of TTT+ were identified by performing a backward regression analysis including the following 16 variables into the model: age, history of cardiac failure, ischaemic heart disease, arrhythmia, hypertension, diabetes mellitus, epilepsy, Parkinson's disease, cerebrovascular disease, folate/vitamin B 12 deficiency, current therapy with anti-psychotics, benzodiazepines, β-blockers, reninangiotensin system blockers, calcium channel blockers and diuretics (SPSS for Windows 11.0, SPSS Inc, Chicago, IL, USA). Given that at least 10 subjects per each variable are required for the analysis, a population size of 161 subjects was considered adequate for the purposes of the study. A P value <0.05 indicated statistical significance.
Results
The test was positive in 28 patients (17.4%). Demographic and clinical characteristics were similar between TTT+ and TTT-subjects (Table 1) . However, patients with TTT+ had a significant fall in SBP after 2 minutes of tilting compared with TTT-patients (-13.8 ± 25.8 versus -3.2 ± 16.1 mmHg, P = 0.006). Thirteen of 28 TTT+ patients (46.4%) had an SBP fall >15 mmHg. A significantly smaller proportion of patients (30 of 133, 22.6%, P = 0.018) with TTT-had SBP fall >15 mmHg at 2 minutes.
Backward regression analysis showed that the degree of SBP fall at 2 minutes of tilting strongly and independently predicted TTT+ (Table 2) . However, the regression model only accounted for 5.8% of the overall variability. The rate of TTT+ in patients with unexplained falls without documented syncope and those with syncope or symptoms of pre-syncope was similar (17.6 and 17.2%).
Discussion
In this study, we sought to identify factors which might allow the early prediction of TTT+. Of the factors we considered, only the fall in SBP at 2 minutes after tilting had significant predictive value (P = 0.014), suggesting the presence of a global deficit in autonomic function in TTT+ patients. When this fall was considered as a percentage of baseline SBP, there was even stronger predictive value (P = 0.007).
Because it is a relatively simple and integral part of the clinical assessment of patients with falls/syncope, we postulated that the measurement of postural drop in SBP should influence the decision to perform a TTT. However, because it is not feasible to apply a complex mathematical model to every patient's TTT results, as a practical solution, we applied an SBP drop at 2 minutes >15 mmHg as a cut-off and found that it retained predictive value (P = 0.018). Using a more familiar cut-off of 20 mmHg did not have predictive value, however.
We did not identify or exclude subjects with postural hypotension prior to testing. As postural hypotension is known to be associated with autonomic dysfunction, this may be a confounding variable.
Although these findings might be applied clinically to improve case selection, the fact that the regression model only accounted for a small proportion of the overall variability indicates that there are other factors that need to be considered, in addition to blood pressure changes, before prediction of a positive test may be achieved.
Key points
• The TTT is an important, well-tolerated, safe test to investigate syncope and falls in elderly people.
• In our series, 17.4% of tests were positive, which is consistent with previously published data.
• A fall in SBP, 2 minutes after 70° head-up tilt, is associated with a positive test result; however, this cannot be considered as a sole predictor of a positive TTT.
• In a clinical setting, a postural decrease in SBP of 15 mmHg may be a more useful predictor than the traditional cut-off of 20 mmHg. Senior physicians' estimates of the likely effects of feeding policies on outcomes prior to the completion of the FOOD trials SIR-The FOOD trials were a family of three multicentre international randomised controlled trials that aimed to estimate the effects of different feeding policies on outcomes of stroke patients [1, 2] . Their purpose was to identify the most effective feeding interventions, which could be included in guidelines so that variation in practice could be reduced and patient outcomes improved. In this study, we aimed to assess the likely impact the trial results would have on actual feeding practices by comparing physicians' estimates of treatment effects with those from the trials themselves.
Methods
Prior 
Results
We received 206 (62%) completed questionnaires. The distributions of clinicians' estimates of effect are shown in Figure 1 . In Trial 1, 179 (90%) clinicians' believed that oral supplements would improve patients' outcomes and 53% provided estimates within the 95% confidence intervals (CI) of the trial estimate. Forty per cent believed supplements would increase the absolute proportion with a good outcome by at least 3%-this size of benefit is statistically very unlikely according to our trial results [1] .
In Trial 2, 169 (85%) thought that early tube feeding would provide better outcomes and 67% of clinicians' estimates lay within the 95% CI of the trial estimate. The trial's estimate with respect to death or MRS 4-5 was only marginally in favour of early tube feeding although the estimate for death alone was a -5.8% (95% CI -12.5 to 0.8%) absolute reduction [2] . This estimate would be more in line with clinicians' expectations.
In Trial 3, 158 (79%) clinicians expected PEG feeding to improve patients' outcomes compared with NG feeding. This was opposite to the effect we actually observed. Despite being the smallest trial with the widest 95% CI, only 21% of clinicians' estimates lay within them. Of course, our trial
